Invention Grant
US09045558B2 Nucleic acids encoding modified human thymic stromal lymphopoietin
有权
编码修饰人胸腺基质淋巴细胞生成素的核酸
- Patent Title: Nucleic acids encoding modified human thymic stromal lymphopoietin
- Patent Title (中): 编码修饰人胸腺基质淋巴细胞生成素的核酸
-
Application No.: US14095524Application Date: 2013-12-03
-
Publication No.: US09045558B2Publication Date: 2015-06-02
- Inventor: Stewart D. Lyman , Kirk P. Van Ness , Raymond Paxton
- Applicant: IMMUNEX CORPORATION
- Applicant Address: US CA Thousand Oaks
- Assignee: IMMUNEX CORPORATION
- Current Assignee: IMMUNEX CORPORATION
- Current Assignee Address: US CA Thousand Oaks
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: C12N5/10
- IPC: C12N5/10 ; C12N15/12 ; C12N15/63 ; C07K14/52 ; C07K14/54 ; A61K38/00
Abstract:
Modified, furin resistant human TSLP polypeptides and polynucleotides encoding the modified human TSLP polypeptides are provided. Pharmaceutical compositions, B and T cell activation agents, assays and methods of use are also described.
Public/Granted literature
- US20140093956A1 Modified Human Thymic Stromal Lymphopoietin Public/Granted day:2014-04-03
Information query
